Celldex Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $469k | 14k | 33.99 |
| 2024-06-30 | $415k | 11k | 37.05 |
| 2024-03-31 | $340k | 8.1k | 41.98 |
| 2023-12-31 | $321k | 8.1k | 39.63 |
| 2023-03-31 | $209k | 5.8k | 36.03 |
| 2022-12-31 | $259k | 5.8k | 44.66 |
| 2022-09-30 | $250k | 8.9k | 28.09 |
| 2022-06-30 | $240k | 8.9k | 26.97 |
| 2022-03-31 | $303k | 8.9k | 34.04 |
| 2021-12-31 | $344k | 8.9k | 38.65 |